Emerald Mutual Fund Advisers Trust Catalyst Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$3.67 - $5.7 $3.98 Million - $6.17 Million	-1,083,284 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$3.89 - $7.43 $4.21 Million - $8.05 Million	1,083,284 New	1,083,284 $5.75 Million
Q2 2018 Jul 31, 2018	SELL	$2.26 - $3.84 $2.12 Million - $3.6 Million	-938,078 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$2.39 - $4.01 $552,873 - $927,625	231,328 Added 32.73%	938,078 $2.24 Million
Q4 2017 Feb 06, 2018	BUY	$2.51 - $4.4 $1.77 Million - $3.11 Million	706,750	706,750 $2.76 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.